Long intergenic non-protein coding RNA 2109 (LINC02109)

LINC02109 (Long intergenic non-protein coding RNA 2109) is a member of the class of long intergenic non-coding RNAs (lincRNAs), which are transcribed RNA molecules longer than 200 nucleotides that do not overlap with protein-coding genes[3]. LINC02109, like other lincRNAs, does not encode a protein and generally functions in the regulation of gene expression, which can include roles such as influencing chromatin architecture or interacting with other RNAs and proteins to modulate transcriptional networks[3]. There is evidence of tissue-specific expression for LINC02109, including expression in human liver cells (hepatocyte subtypes)[2], but its precise molecular functions, interacting partners, or value as a therapeutic target have not been established. Current literature does not suggest that LINC02109 is a validated therapeutic target or that it interacts with drugs or constitutes a clinical biomarker. It is primarily of research interest in the context of understanding lncRNA functions in gene regulation and disease progression, especially cancer[2][3].

Other names

LINC02109